CN was able to reduce vascular oxidative damage and inflammatory biomarkers in WHFDS, explaining the normalization of endothelial function achieved under metabolic syndrome conditions by the activation of the Nrf2 pathway. The gene discussed is NFE2L2; the disease is metabolic syndrome.